The investigators propose to assess the effects of including mushrooms as part of a healthy eating pattern on indices of perceived mental health/anxiety/depression, along with risk factors for cardiovascular disease and type 2 diabetes.
The investigators hypothesize that consuming mushrooms as part of a healthy eating pattern will lead to greater improvements in fasting insulin concentrations and systolic and diastolic blood pressures. The brain health-related outcomes and other cardiometabolic risk outcomes (e.g. lipoprotein particle size) are exploratory due to the paucity of human research addressing these important topics. Collectively, this short-term (8-week) randomized, controlled feeding trial will provide important pilot data to inform the plausibility, focus, and design of longer-term intervention trials, consistent with The Mushroom Council's research agenda.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Enrollment
53
During the 2-week baseline period all participants will consume their usual, unrestricted self-chosen diets. During intervention weeks 1-8, all participants will consume the same Mediterranean-style diet, rich in fruits and seafoods and lower in dairy, designed to meet their estimated energy needs. The mushroom group will consume 0.5 cups/day of cooked mushrooms (white button mushrooms and yellow oyster mushrooms on 4 and 3 days/week, respectively). All foods will be provided to subjects during the intervention to achieve the desired eating pattern.
During the 2-week baseline period all participants will consume their usual, unrestricted self-chosen diets. During intervention weeks 1-8, all participants will consume the same Mediterranean-style diet, rich in fruits and seafoods and lower in dairy, designed to meet their estimated energy needs. The control group will not consume mushrooms at any point. All foods will be provided to subjects during the intervention to achieve the desired eating pattern.
Purdue University
West Lafayette, Indiana, United States
Purdue University - Stone Hall 700 W State St
West Lafayette, Indiana, United States
Change in perceived depression from baseline to post-intervention
Beck's Depression Inventory questionnaire
Time frame: 8 weeks
Change in perceived depression from baseline to post-intervention
Patient Health Questionnaire-9
Time frame: 8 weeks
Change in perceived anxiety from baseline to post-intervention
General Anxiety Disorder-7 questionnaire
Time frame: 8 weeks
Change in cognitive function from baseline to post-intervention
Repeatable Battery for the Assessment of Neuropsychological Status
Time frame: 8 weeks
Change in perceived daily mood from baseline to post-intervention
Profile of Mood States
Time frame: 8 weeks
Change in perceived quality of life from baseline to post-intervention
Medical Outcomes Study 36-Item Short Form Health Survey Version 2
Time frame: 8 weeks
Risk factors for cardiovascular disease
Blood pressure
Time frame: 8 weeks
Risk factors for cardiovascular disease
Complete metabolic panel
Time frame: 8 weeks
Risk factors for cardiovascular disease
Lipoprotein Particle Plus (LPP+) Panel
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Risk factors for type 2 diabetes
Complete metabolic panel
Time frame: 8 weeks
Change in immunity/inflammation markers
Complete Cytokine 13 Panel -- all outcomes reported as pg/mL
Time frame: 8 weeks
Change in immunity/inflammation markers
Complete Immunoglobulin Panel -- all outcomes reported as mg/dL
Time frame: 8 weeks
Body weight
Measures of weight (kg)
Time frame: 8 weeks
Gut microbiota
Stool samples
Time frame: 8 weeks